NAGE
Niagen Bioscience, Inc. Common Stock
Nasdaq · usd
Niagen Bioscience, Inc. Common Stock (NAGE) trades at $2.04 (+1.49%) as of 6:54:53 PM EST on Nov 17, 2026, -18.40% over the past month. Market cap is $159.19M, with 8.9 days to cover in short interest.
Stock performance
How Niagen Bioscience, Inc. Common Stock (NAGE) stock has performed from one day to one year, with its 52-week range.
- 1D
- +1.49%
- 1W
- -5.12%
- 1M
- -18.40%
- YTD
- -67.92%
- 1Y
- -70.26%
- 52-wk range
- $1.95 – $7.12
Key statistics
Today's trading snapshot for NAGE: day range, open, previous close, volume and market cap.
- Day range
- $1.95 – $2.05
- Open
- $2.00
- Prev close
- $2.01
- Volume
- 1.03M
- Market cap
- $159.19M
- Shares out
- 79.2M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Niagen Bioscience, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- 15.55
- P/S
- 1.30
- P/B
- 1.92
- P/FCF
- 34.76
- ROE
- 12.3%
- ROA
- 9.4%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 16, 2026
8-K filings
Material corporate events Niagen Bioscience, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 4, 2026
On November 4, 2026, Niagen Bioscience, Inc. (the "Company") issued a press release announcing its earnings for the quarter ended September 30, 2026.
- Investor presentationAug 4, 2026
On August 4, 2026, the Company released a corporate presentation which it made available on its website.
- Annual meeting resultsJun 29, 2026
Set forth below are the results of the matters submitted for a vote of stockholders at the Company's 2026 Annual Meeting. Proposal 1 — Election of directors. The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders...
- Investor presentationMay 6, 2026
On May 6, 2026, the Company released a corporate presentation which it made available on its website.
- Share repurchase programMar 19, 2026
the Board of Directors (the "Board") of Niagen Bioscience, Inc. (the "Company") approved an increase in the authorization under the Company's share repurchase program. Under the amended authorization, the Company may repurchase up to $20.0 million of its outstanding common stock, representing an increase from the previously authorized $10.0 million share repurchase program approved by the Board on October 31, 2025.
Dividend history and stock splits
Niagen Bioscience, Inc. Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 3.1887751-for-1Dec 7, 2006
NAGE short interest
How heavily NAGE is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 8.9
- Short interest
- 4.35M
- Avg volume
- 487.93K
As of · reported to FINRA twice monthly.
NAGE news
The latest news and headlines about Niagen Bioscience, Inc. Common Stock (NAGE).
- Niagen Bioscience (NAGE) Reports Q3 Loss, Lags Revenue EstimatesnegativeZacks Investment Research· Nov 4, 2026
- Will Coherus Oncology (CHRS) Report Negative Earnings Next Week? What You Should KnownegativeZacks Investment Research· Nov 2, 2026
- Earnings Preview: Niagen Bioscience (NAGE) Q3 Earnings Expected to DeclinenegativeZacks Investment Research· Oct 28, 2026
- Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion— Stock Jumps After-Hours (UPDATED)positiveBenzinga· Mar 5, 2026
- National Advertising Division Finds Certain Reus Cata-Kor NAD+ Claims Supported; Recommends Others Be Modified or DiscontinuedneutralGlobeNewswire Inc.· Oct 13, 2025
Frequently asked questions
What is the Niagen Bioscience, Inc. Common Stock (NAGE) stock price today?
Niagen Bioscience, Inc. Common Stock (NAGE) is trading at $2.04 (+1.49% on the day) as of 6:54:53 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Niagen Bioscience, Inc. Common Stock?
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions.
What is the short interest in NAGE?
As of Oct 30, 2026, NAGE has 4.35M shares short and 8.9 days to cover.
What exchange is NAGE listed on?
Niagen Bioscience, Inc. Common Stock (NAGE) trades on Nasdaq in USD, in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry.
Build with AI
Build an analysis of NAGE with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a NAGE analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.